Journal

Publisher agreements, university affiliations and hospital partnerships can matter without proving that a healthcare AI product delivers the outcome in its headline.

Five links can repeat one company's number without independently checking it. Healthcare AI needs better source tracing, not longer reference lists.

A tool used by staff at thousands of sites has achieved reach. Hospital adoption, approved deployment and sustained clinical use require different evidence.

One clinical AI study produced three competing victory stories. Reading the outcome measures explains how the headlines can diverge so sharply.

OpenEvidence's popularity claim draws on real observations. The crucial question is whether the denominator supports the headline readers take away.

OpenEvidence's daily-use claims deserve the same scrutiny as its clinical answers. The missing detail is how people, activity and time are counted.

Compare medical word games by what they ask you to do: spell a term, interpret word parts, solve a clue, identify a diagnosis or connect clinical concepts.

Where can doctors play a medical connections game? Compare iatroX clinical connections, Curie and Steradian's MedMini, then try an original grouping example.

Healthcare AI expansion depends on local financing, clinical pathways, data access and regulation, not simply translating a successful US product.

Hospitals can build, buy or combine clinical AI components, but local fit must be weighed against maintenance, evidence and operational responsibility.

Healthcare AI consolidation may turn on complementary assets, integration rights and clinical capability rather than model performance alone.

Free clinical AI still has operating costs: compare advertising, enterprise contracts and paid education without confusing price with independence.